Updates of Healthcare Implementation Communique (SUT) published in Turkey in January 2020

04

Feb 2020

In January 2020,  the Reimbursement Commission made changes to the Healthcare Implementation Communique. The main changes relate to the addition of new laboratory test codes, procedure codes, new devices related to the ophthalmology, and price changing of materials related to interventional radiology.

Major updates include the following:

  • Three new services have been added to Annex-2/C ("case-based" reimbursement method)
  • Three new services have been added to Annex-2/B ("fee-for-service" reimbursement method)
  • Nine new devices were added to the eye devices category
  • The price list of drugs abroad has been updated
  • In the Annex-2/B, the old laboratory codes were deleted (550 services) and replaced with new codes starting with the letter “L” and new codes were added (1948 services)
  • In the Annex 2A/2 services, which can be billed outside of the "case-based" reimbursement method, the old laboratory codes (96 services) were deleted and replaced with new ones starting with the letter "L" and new services were added (116 services)
  • In devices for interventional radiology, price changes were made in two devices, and one device was added
  • In the text of Healthcare Implementation Communique, rule changes were made in outpatient treatments to be invoiced by the distances to be taken as a basis for the road expenses, the payment of dental treatments and the payment per service method

See the full details here.

Visit our online school if you want to learn about the Turkish hospital reimbursement system.

Our online seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Turkish.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more